These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1492385)

  • 21. An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition.
    Ofosu FA; Smith LM; Anvari N; Blajchman MA
    Thromb Haemost; 1988 Oct; 60(2):193-8. PubMed ID: 2851191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
    Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
    Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
    Maaroufi RM; Giordano P; Triadou P; Tapon-Bretaudière J; Dautzenberg MD; Fischer AM
    Thromb Res; 2007; 120(4):615-21. PubMed ID: 17222891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The relation between the physicochemical structure and the anticoagulant effects of polysulfated chitosan derivatives].
    Drozd NN; Sher AI; Makarov VA; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1994; 57(4):42-5. PubMed ID: 7950784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulant activity of a sulfated chitosan.
    Vongchan P; Sajomsang W; Subyen D; Kongtawelert P
    Carbohydr Res; 2002 Jul; 337(13):1239-42. PubMed ID: 12110200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfated N-(carboxymethyl)chitosans: novel blood anticoagulants.
    Muzzarelli RA; Tanfani F; Emanuelli M; Pace DP; Chiurazzi E; Piani M
    Carbohydr Res; 1984 Mar; 126(2):225-31. PubMed ID: 6713433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of antithrombin activity of the polysulphate chitosan derivatives in in vivo and in vitro system.
    Drozd NN; Sher AI; Makarov VA; Galbraikh LS; Vikhoreva GA; Gorbachiova IN
    Thromb Res; 2001 Jun; 102(5):445-55. PubMed ID: 11395130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanism of anticoagulant activity of a novel heparinoid sulfated glucoside-bearing polymer.
    Sakamoto N; Kishida A; Maruyama I; Akashi M
    J Biomater Sci Polym Ed; 1997; 8(7):545-53. PubMed ID: 9195333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sulfated derivatives of chitosan on some blood coagulant factors.
    Hirano S; Tanaka Y; Hasegawa M; Tobetto K; Nishioka A
    Carbohydr Res; 1985 Mar; 137():205-15. PubMed ID: 3986847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A glycosaminoglycan inhibitor of thrombin: a new mechanism for abnormal hemostatic assays in cancer.
    Liebman HA; Comenzo R; Allen ST; Dilorio JM
    Am J Hematol; 1991 Sep; 38(1):24-9. PubMed ID: 1897511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of the heparin-neutralizing effect of plasma in disorders of hemostasis (clinical use of the "heparin-thrombin coagulation time")].
    Misz M; Boda Z; Rák K
    Orv Hetil; 1977 Sep; 118(37):2195-9. PubMed ID: 917513
    [No Abstract]   [Full Text] [Related]  

  • 34. Sulfonation of papain-treated chitosan and its mechanism for anticoagulant activity.
    Suwan J; Zhang Z; Li B; Vongchan P; Meepowpan P; Zhang F; Mousa SA; Mousa S; Premanode B; Kongtawelert P; Linhardt RJ
    Carbohydr Res; 2009 Jul; 344(10):1190-6. PubMed ID: 19476923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of chitosan (poly-N-acetyl glucosamine) on lingual hemostasis in heparinized rabbits.
    Klokkevold PR; Fukayama H; Sung EC; Bertolami CN
    J Oral Maxillofac Surg; 1999 Jan; 57(1):49-52. PubMed ID: 9915395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulant activity of sulfatide and its anti-thrombotic effect in rabbit.
    Hara A; Kutsukake Y; Uemura KI; Taketomi T
    J Biochem; 1993 Jun; 113(6):781-5. PubMed ID: 8370675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin III-mediated blood coagulation inhibitory activity of chitosan sulfate derivatized with different functional groups.
    Chandika P; Heo SY; Oh GW; Choi IW; Park WS; Jung WK
    Int J Biol Macromol; 2020 Oct; 161():1552-1558. PubMed ID: 32791278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternating bioactivity of polymeric layer-by-layer assemblies: anti- vs procoagulation of human blood on chitosan and dextran sulfate layers.
    Serizawa T; Yamaguchi M; Matsuyama T; Akashi M
    Biomacromolecules; 2000; 1(3):306-9. PubMed ID: 11710116
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of the hydrolytic activity of thrombin by chitin heparinoids.
    Nishimura S; Nishi N; Tokura S; Okiei W; Somorin O
    Carbohydr Res; 1986 Nov; 156():286-92. PubMed ID: 3815407
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative effects of heparin and paritol-C upon blood coagulation and prothrombin time and upon the plasma antithrombin level.
    HOWE GW; ARMBRUST CA; McPEAK EM
    J Lab Clin Med; 1951 Oct; 38(4):542-9. PubMed ID: 14889033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.